Catherine M. Szyman Insider Trading Activity
Every SEC Form 4 transaction reported by Catherine M. Szyman, sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Catherine M. Szyman buying or selling?
Catherine M. Szyman reported 1 open-market buys ($533.7K) and 53 sells ($42.1M) across 54 Form 4 filings at 2 companies — a net selling position of $41.6M.
Source: SEC EDGAR Form 4
What stands out
- Catherine M. Szyman has reported Form 4 transactions at 2 companies; the most active, Edwards Lifesciences Corp (EW), accounts for 53 of 54 filings (98%).
- The most recent Form 4 was accepted on Feb 15, 2024 (2 years ago).
- No open-market purchases or sales were reported in the last 12 months.
Key Statistics (as of Feb 15, 2024)
Insider sentiment
Net sellingNet insider flow of $41.6M in net selling, filed between May 24, 2018 – Feb 15, 2024.
Companies Catherine M. Szyman files for
Recent Catherine M. Szyman transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Feb 15, 2024 | EW | CVP, Critical Care | Sale | 47.0K | $4.0M | SEC ↗ |
| Oct 10, 2023 | EW | CVP, Critical Care | Sale | 5.0K | $363.4K | SEC ↗ |
| Sep 8, 2023 | EW | CVP, Critical Care | Sale | 5.0K | $380.0K | SEC ↗ |
| Aug 9, 2023 | EW | CVP, Critical Care | Sale | 5.0K | $393.2K | SEC ↗ |
| Jul 10, 2023 | EW | CVP, Critical Care | Sale | 5.0K | $452.6K | SEC ↗ |
| Jun 14, 2023 | EW | CVP, Critical Care | Sale | 5.0K | $429.0K | SEC ↗ |
| May 9, 2023 | EW | CVP, Critical Care | Sale | 75.6K | $6.7M | SEC ↗ |
| May 5, 2022 | EW | CVP, Critical Care | Sale | 23.4K | $2.5M | SEC ↗ |
| Apr 11, 2022 | EW | CVP, Critical Care | Sale | 20.0K | $2.4M | SEC ↗ |
| Mar 14, 2022 | EW | CVP, Critical Care | Sale | 20.0K | $2.1M | SEC ↗ |
| Feb 19, 2022 | EW | CVP, Critical Care | Sale | 20.0K | $2.1M | SEC ↗ |
| Jan 15, 2022 | EW | CVP, Critical Care | Sale | 10.0K | $1.2M | SEC ↗ |
| Dec 18, 2021 | EW | CVP, Critical Care | Sale | 10.0K | $1.2M | SEC ↗ |
| Nov 19, 2021 | EW | CVP, Critical Care | Sale | 10.0K | $1.2M | SEC ↗ |
| Oct 18, 2021 | EW | CVP, Critical Care | Sale | 9.7K | $1.1M | SEC ↗ |
| Sep 9, 2021 | EW | CVP, Critical Care | Sale | 9.7K | $1.2M | SEC ↗ |
| Aug 3, 2021 | EW | CVP, Critical Care | Sale | 15.0K | $1.7M | SEC ↗ |
| Jun 16, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $345.0K | SEC ↗ |
| May 28, 2021 | EW | CVP, Critical Care | Sale | 2.1K | $196.4K | SEC ↗ |
| May 25, 2021 | EW | CVP, Critical Care | Sale | 4.7K | $448.3K | SEC ↗ |
| May 7, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $311.3K | SEC ↗ |
| Apr 23, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $319.9K | SEC ↗ |
| Mar 15, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $276.7K | SEC ↗ |
| Feb 17, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $298.9K | SEC ↗ |
| Jan 16, 2021 | EW | CVP, Critical Care | Sale | 3.4K | $295.8K | SEC ↗ |
Showing the 25 most recent filings of 54. Screen every filing.
Catherine M. Szyman insider trading FAQ
Is Catherine M. Szyman buying or selling?
Across 54 SEC Form 4 filings, Catherine M. Szyman reported 1 open-market purchases totaling $533.7K and 53 sales totaling $42.1M — a net selling position of $41.6M.
Which companies does Catherine M. Szyman file Form 4s for?
Catherine M. Szyman has reported insider transactions at 2 companies, most often Edwards Lifesciences Corp (EW), Inari Medical, Inc. (NARI).
How far back does Catherine M. Szyman's filing history go?
Trabud holds Catherine M. Szyman's SEC Form 4 filings from May 24, 2018 – Feb 15, 2024, sourced directly from SEC EDGAR.
Where does Trabud get Catherine M. Szyman's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Catherine M. Szyman and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener